AI-assisted, human-published
10/17/2025 /Funding Events
BridGene Biosciences Secures $28M in Series B+ Financing
Bayland Capital leads the round with participation from GTJA Investment Group, Proxima Ventures, Lapam Capital, and Grains Valley Venture Capital. BridGene pioneers small-molecule drugs targeting challenging sites and focuses on diverse clinical programs.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com